Preprint Open Access

Influenza and acellular pertussis vaccines not only fail to protect, they increase susceptibility and severity of disease upon infection – benefits are overrated and the risks are being ignored

Arumugham, Vinu


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:cnt="http://www.w3.org/2011/content#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.2532167">
    <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
    <dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.2532167</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.2532167"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Arumugham, Vinu</foaf:name>
        <foaf:givenName>Vinu</foaf:givenName>
        <foaf:familyName>Arumugham</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:title>Influenza and acellular pertussis vaccines not only fail to protect, they increase susceptibility and severity of disease upon infection – benefits are overrated and the risks are being ignored</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2019</dct:issued>
    <dcat:keyword>influenza</dcat:keyword>
    <dcat:keyword>vaccine</dcat:keyword>
    <dcat:keyword>pertussis</dcat:keyword>
    <dcat:keyword>mucosal immunity</dcat:keyword>
    <dcat:keyword>cell mediated immunity</dcat:keyword>
    <dcat:keyword>allergy</dcat:keyword>
    <dcat:keyword>asthma</dcat:keyword>
    <dcat:keyword>colonization</dcat:keyword>
    <dcat:keyword>linked epitope suppression</dcat:keyword>
    <dcat:keyword>Th2</dcat:keyword>
    <dcat:keyword>aluminum adjuvant</dcat:keyword>
    <dcat:keyword>multiple sclerosis</dcat:keyword>
    <dcat:keyword>autism</dcat:keyword>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2019-01-05</dct:issued>
    <owl:sameAs rdf:resource="https://zenodo.org/record/2532167"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/2532167</skos:notation>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.2532166"/>
    <dct:description>&lt;p&gt;The influenza vaccine fails often. The influenza vaccines cause the development of IgE mediated&lt;br&gt; allergy to the influenza virus. The reason for failure include antigenic mismatch between vaccine strain&lt;br&gt; and wild virus, IgE mediated antigen neutralization, etc. Naturally acquired immunity against influenza&lt;br&gt; lasts for decades. Vaccine based immunity lasts for a few months. Replacing natural immunity with&lt;br&gt; vaccine-based immunity, progressively increases susceptibility over time. In 2016-18, between 46 and&lt;br&gt; 68% of patients admitted to the ICU for severe influenza were vaccinated with the influenza vaccine, in&lt;br&gt; California. The influenza vaccine uptake in the general population in California during that same period&lt;br&gt; was between 40-48%. This adds to evidence that not only does the influenza vaccine fail, it can&lt;br&gt; contribute to increased disease severity. The increase in disease severity is due to patients suffering an&lt;br&gt; allergic reaction against the virus, concurrent with the influenza infection.&lt;br&gt; The acellular pertussis vaccine (APV) fails to protect for more than a year in most patients, fails to&lt;br&gt; provide mucosal immunity, fails to provide cell mediated immunity and fails to protect against airway&lt;br&gt; colonization with Bordetella pertussis (BP) bacteria. Therefore the APV causes asymptomatic&lt;br&gt; spreading of BP. The exact opposite effect of herd immunity - herd spreading. The APV causes IgE&lt;br&gt; mediated sensitization directed against BP antigens. Therefore once colonized, continuing exposure to&lt;br&gt; BP antigens results in asthma. Colonization with BP can cause multiple sclerosis. The APV contains&lt;br&gt; cow&amp;rsquo;s milk proteins used to manufacture the vaccine. The milk proteins include bovine casein, bovine&lt;br&gt; insulin and bovine folate receptor proteins. The result is the development of milk allergy, type 1&lt;br&gt; diabetes and autism respectively. Colonization can induce immune tolerance to BP, making an infection&lt;br&gt; even more dangerous and rendering the patient potentially unprotectable for life with a future pertussis&lt;br&gt; vaccine.&lt;/p&gt; &lt;p&gt;&amp;nbsp;&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dcat:distribution>
      <dcat:Distribution>
        <dct:rights>
          <dct:RightsStatement rdf:about="https://creativecommons.org/licenses/by/4.0/legalcode">
            <rdfs:label>Creative Commons Attribution 4.0 International</rdfs:label>
          </dct:RightsStatement>
        </dct:rights>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.2532167"/>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>
1,705
465
views
downloads
All versions This version
Views 1,7051,706
Downloads 465465
Data volume 27.6 MB27.6 MB
Unique views 1,5431,544
Unique downloads 411411

Share

Cite as